We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+30.44%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$270M
AUM Growth
+$53.8M
(+25%)
Cap. Flow
+$13.5M
Cap. Flow
% of AUM
4.99%
Top 10 Holdings %
Top 10 Hldgs %
73.27%
Holding
33
New
7
Increased
5
Reduced
7
Closed
4
Top Buys
| 1 |
Kura Oncology
KURA
|
+$19.3M |
| 2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
+$19.1M |
| 3 |
Cytokinetics
CYTK
|
+$13.9M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
+$9.48M |
| 5 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$8.55M |
Top Sells
| 1 |
Atara Biotherapeutics
ATRA
|
+$25.3M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
+$11.8M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$8.12M |
| 4 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
+$2.58M |
| 5 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
+$1.98M |
Sector Composition
| 1 | Healthcare | 84.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bausch Health
BHC
$1.8B
| – | – |
0
| – | – |
|
27
Gilead Sciences
GILD
$164B
| – | – |
0
| – | – |
|
28
Gyre Therapeutics
GYRE
$735M
| – | – |
-498
| Closed | -$261K |
|
29
Jazz Pharmaceuticals
JAZZ
$15.1B
| – | – |
0
| – | – |
|
|
RGLS
30
DELISTED
Regulus Therapeutics
RGLS
| – | – |
0
| – | – |
|
|
CASC
31
DELISTED
Cascadian Therapeutics, Inc.
CASC
| – | – |
-157,250
| Closed | -$2.58M |
|
|
OREX
32
DELISTED
Orexigen Therapeutics, Inc.
OREX
| – | – |
-93,796
| Closed | -$1.98M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM